Experienced in Riboflavin Transporter Deficiency Neuronopathy

Jinzhou Tian

Beijing, CN 
Experienced in Riboflavin Transporter Deficiency Neuronopathy
Beijing, CN 
OverviewLocationsClinical Research

Overview

Jinzhou Tian practices in Beijing, China. Tian is rated as an Experienced expert by MediFind in the treatment of Riboflavin Transporter Deficiency Neuronopathy. Their top areas of expertise are Dementia, Primary Lateral Sclerosis, Black Hairy Tongue, and Alzheimer's Disease.

Their clinical research consists of co-authoring 51 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Riboflavin Transporter Deficiency Neuronopathy.

Locations

Beijing, 100000, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

The Safety and Efficacy of 1612 Capsules in Treatment of aMnestic Mild Cognitive Impairment: a 52-week, Double Blind,Randomized, Parallel,Placebo Controlled Trial.
The Safety and Efficacy of 1612 Capsules in Treatment of aMnestic Mild Cognitive Impairment: a 52-week, Double Blind,Randomized, Parallel,Placebo Controlled Trial.
Enrollment Status: Withdrawn
Publish Date: March 04, 2021
Intervention Type: Drug
Study Phase: Phase 4
Efficacy and Safety of Twice Daily TMBCZG in Mild to Moderate Vascular Dementia: Randomized, Double Blind, Parallel Group, Placebo Controlled, Multicenter Trial
Efficacy and Safety of Twice Daily TMBCZG in Mild to Moderate Vascular Dementia: Randomized, Double Blind, Parallel Group, Placebo Controlled, Multicenter Trial
Enrollment Status: Completed
Publish Date: March 02, 2021
Intervention Type: Drug, Other
Study Phase: Phase 2
The Efficacy and Safety of Qinggongshoutao Bolus for aMnestic Mild Cognitive Impairment: A 52- Week Randomized, Double-blind, Controlled,Three Arms, Multi-center Study
The Efficacy and Safety of Qinggongshoutao Bolus for aMnestic Mild Cognitive Impairment: A 52- Week Randomized, Double-blind, Controlled,Three Arms, Multi-center Study
Enrollment Status: Completed
Publish Date: October 23, 2018
Intervention Type: Drug
Study Phase: Phase 4
View 2 Less Clinical Trials

51 Total Publications

Preparation and Evaluation of Gastrodin-Ferulic Acid Co-Loaded Liposome Gel Patches for the Treatment of Migraine.
Preparation and Evaluation of Gastrodin-Ferulic Acid Co-Loaded Liposome Gel Patches for the Treatment of Migraine.
Journal: Drug development and industrial pharmacy
Published: May 29, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Tian's expertise for a condition
ConditionClose
      View All 7 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile